Last reviewed · How we verify

injection of microfat and plasma rich platelet PRP

Assistance Publique Hopitaux De Marseille · Phase 1 active Small molecule Quality 0/100

injection of microfat and plasma rich platelet PRP is a Small molecule drug developed by Assistance Publique Hopitaux De Marseille. It is currently in Phase 1 development.

At a glance

Generic nameinjection of microfat and plasma rich platelet PRP
SponsorAssistance Publique Hopitaux De Marseille
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about injection of microfat and plasma rich platelet PRP

What is injection of microfat and plasma rich platelet PRP?

injection of microfat and plasma rich platelet PRP is a Small molecule drug developed by Assistance Publique Hopitaux De Marseille.

Who makes injection of microfat and plasma rich platelet PRP?

injection of microfat and plasma rich platelet PRP is developed by Assistance Publique Hopitaux De Marseille (see full Assistance Publique Hopitaux De Marseille pipeline at /company/assistance-publique-hopitaux-de-marseille).

What development phase is injection of microfat and plasma rich platelet PRP in?

injection of microfat and plasma rich platelet PRP is in Phase 1.

Related